|
Nick has had one of the most successful and respected careers of any healthcare executive, and has done some of the largest and most important financing and corporate licensing deals in the healthcare industry. From 2000-2002, he was President & C.E.O. and the first employee of Locus Discovery, where in two years he raised $83 million in two venture financings, hired over 50 employees, started 12 drug discovery programs, built one of the most powerful supercomputers in the world, and earned for the company the accolade "One of the 10 hottest biotech start-ups" from Drug Discovery Today magazine. Prior to Locus, from 1995-2000 he was Sr. Vice President Corporate Development & Investor Relations at Guilford Pharmaceuticals, where he concluded a $465 million deal with Amgen and a $100 million deal with Rhone-Poulenc Rorer. His deals have twice been nominated for "Allicense Deal of the Year". Prior to Guilford, from 1991-1995 he was Sr. Director, Business Development at Cephalon; from 1988-1991 Sr. Manager, Strategic Marketing at Bristol-Myers Squibb; from 1985-1988 positions in Finance and Business Development at Johnson & Johnson Corporation (McNeil Pharmaceutical); and has also worked in the research laboratories at the Mt. Sinai Medical Center from 1982-1983. He holds a M.B.A. from the State University of New York at Albany, M.S. Biology from Indiana University, and B.S. Biology from Marist College.
| 